Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks

An FDA advisory panel has endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer.

STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at statnews.com →

More in Health & Medicine

More from Wednesday 23 September →